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Role of chloride channels in afferent arteriolar constriction. The effects
of IAA-94, a chloride channel blocker, and/or low chloride perfusate on
afferent arteriolar (AA) constriction by angiotensin 11 (Ang II), norepi-
nephrine (NE) and increasing pressure (80 to 160 mm Hg) were assessed,
using isolated perfused hydronephrotic kidneys. In the first series of
experiments, Ang 11(0.3 nM) constricted AAs by 33 3% (N = 5, P <
0.01). Subsequent addition of diltiazem (10 .rM) restored the decrements
in the AA diameters. In the presence of diltiazem (10 jM), Increasing
pressure did not constrict AAs. In the second series of experiments,
elevation of pressure constricted AAs by 20 2% (N = 7, P < 0.01).
Subsequent addition of IAA-94 (30 j.rM) failed to alter the basal AA
diameter and myogenic responsiveness. However, Ang Il-induced AA
constriction was abolished by IAA-94. In the third series of experiments,
decreasing extracellular chloride exaggerated AA constriction by 0.1 n of
Ang II (from 13 2 to 20 3%, N = 6, P < 0.05). Similarly, low chloride
perfusate enhanced NE (0.1 rM)-induced AA constriction (from 14 2 to
19 2%, N = 6, P < 0.05). In contrast, myogenic responsiveness was not
influenced by reducing chloride concentrations. The present data provide
evidence that both Ang II and NE induce AA constriction by opening
chloride channels and subsequent activation of voltage-dependent calcium
channels, and suggest that the myogenic response is mediated by activating
voltage-dependent calcium channels independently of chloride channels.
An accumulating body of evidence indicates that angiotensin II
(Ang II) is a potent renal vasoconstrictor. Recent studies have
demonstrated that Ang II constricts renal microvasculature, in-
cluding afferent and efferent arterioles [1—3]. In addition to its
physiological role in renal hemodynamics and cardiovascular
homeostasis, Ang II has been shown to play an important role in
mediating pathophysiological renal vasoconstriction in a wide
array of disorders, including hypertension and progressive renal
disease [4]. Thus, previous studies have demonstrated that the
inhibition of renin-angiotensin axis induces beneficial effects on
renal functions under the conditions mentioned above [5, 6].
Kidneys exhibit remarkable capacity to maintain blood flow
constant in the face of marked variations in blood pressure.
Recently, investigators have demonstrated that increasing pres-
sure induces vasoconstriction of preglomerular microvessels, in-
cluding the afferent arteriole [7—9]. However, this renal autoreg-
ulatory response seems to be deteriorated in diverse settings, such
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as hypertension and remnant kidneys [10, 11], thereby possibly
worsening renal injury.
On the basis of the above considerations, the elucidation of the
mechanisms whereby Ang II and pressure induce renal vasocon-
striction would be of great interest, and could provide a theoret-
ical framework for developing strategies for the managements of
diverse renal functional diseases. Recent investigations indicate
that both Ang II and pressure elicit membrane depolarization
[12—15]. However, the data concerning the ionic basis for the
alterations in membrane potential by these constrictor stimuli in
the renal microcirculation were limited and controversial [13, 14,
16]. We have previously provided evidence that endothelin con-
stricts the afferent arteriole by opening chloride channels, which
induces membrane depolarization, thereby activating voltage-
dependent calcium channels [17]. Furthermore, although there is
the evidence against the involvement of chloride channels in
efferent arteriolar constriction [18], electrophysiological studies
suggest that calcium-activated chloride channels are present on
preglomerular vessels, including the afferent arteriole [13, 19].
Nevertheless, the potential roles of chloride channels in afferent
arteriolar responses to the other constrictor stimuli have not been
fully examined.
In the present study, we assessed afferent arteriolar responses
to Ang II and perfusion pressure. Furthermore, the influences of
either IAA-94, a potent and selective chloride channel blocker
possessing extremely weak inhibitory effects on chloride trans-
porter and exchanger [20], or low chloride perfusate on afferent
arteriolar constriction by Ang II and pressure were examined. Our
results indicated that Ang TI-induced afferent arteriolar constric-
tion was blocked by IAA-94 and potentiated by low chloride
perfusate, but both maneuvers failed to modify myogenic respon-
siveness, suggesting that Ang 11 constricts afferent arterioles by
opening chloride channels and consequent activation of voltage-
dependent calcium channels, whereas the myogenic response is
mediated by activating voltage-dependent calcium channels inde-
pendently of chloride channels on the afferent arteriole.
Methods
Thirty-five adult male Sprague-Dawicy rats (Charles River
Japan, Atsugi, Kanagawa, Japan) were utilized for the induction
of hydronephrosis. The right ureter was exposed by a small
abdominal incision and ligated under ether anesthesia (Showa
Chemicals, Tokyo, Japan), After 8 to 10 weeks from the surgery,
renal tubular atrophy had progressed to a stage that allowed
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direct microscopic visualization of renal microvessels [21]. At this
point, the hydronephrotic kidneys were excised and studied.
For the perfusion of the hydronephrotic kidneys, the rats were
anesthetized with ether. The renal artery of the hydronephrotic
kidney was cannulated by introducing the perfusion cannula
through the mesenteric artery and across the aorta. Perfusion with
warm, oxygenated media (pH 7.4) was initiated during this
cannulation procedure. The hydronephrotic kidney was excised
and renal capsule was removed to promote the visualization of
microvessels. Then, the kidney was placed on the stage of an
inverted microscope (Model T041, Olympus), modified to accom-
modate a heated chamber equipped with a thin glass viewing port
on the bottom surface.
The perfusion media consisted of Krebs-Ringer bicarbonate
buffer (in mM: NaCI 110, KCI 5, NaHCO3 25, CaCl2 2, MgSO4 2.5,
Na2HPO4 0.6, NaH2PO4 0.15) containing 5.1 gIlOO ml bovine
serum albumin (Fraction V; Sigma, St. Louis, MO, USA), 5 mM
D-glucose and a complement of amino acids, as detailed previ-
ously [22]. Perfusate was provided to the kidney at a constant
pressure from a pressurized chamber. The chamber pressure was
maintained by the inflow of warm, hydrated gas of 95% 02-5%
C02, which exited through an adjustable back-pressure regulator
(model 1OBP; Fairchild Industrial Products, Winston Salem, NC,
USA). Perfusion pressure was measured at the level of renal
artery and initially set at 80 mm Hg. The effluent was returned to
the pressurized chamber by two rolling pumps (Masterfiex, Chi-
cago, IL, USA).
Kidneys were allowed to equilibrate for at least 30 minutes
before basal measurements were obtained and then experimental
manipulations were initiated. Video images of the renal microves-
sels were obtained utilizing a CCD video camera (model lCD-
42AC; Ikeganii, Tokyo, Japan) and recorded by a video cassette
recorder (model EVO-9850, Sony). To determine the vessel
diameter, the video recording was transmitted to an IBM-AT
computer equipped with a display board (model TARGA+;
Truevision, Indianapolis, IN, USA). Vessel diameters were esti-
mated with an automated program custom designed to determine
the mean distance between parallel edges. The renal microvessel
diameters were obtained during the plateau of the response. A
segment of afferent arterioles near the parent interlobular artery,
approximately 10 jm in length, was scanned at 2 to 5 second
intervals [23].
In the first series of experiments, we assessed the effects of
diltiazem, a calcium channel blocker, on afferent arteriolar con-
striction by Ang 11 and blood pressure. After the basal vessel
diameter was observed, the kidneys (N = 4) were treated with
Ang II in a cumulative manner to achieve concentrations of 0.03,
0.1 and 0.3 nM. In the presence of Ang 11(0.3 nM), diltiazem (0.1
to 10 tLM) was administered directly to the perfusate. Subse-
quently, renal arterial pressure was increased from 80 to 120 and
then to 160 mm Hg. Finally, perfusion pressure was decreased to
80 mm Hg. Renal arterial pressure was kept constant at each
pressure for 90 seconds.
In the second series of experiments, the ability of IAA-94 to
modify afferent arteriolar vasoconstriction by Ang II or blood
pressure was assessed in six kidneys. Initially, afferent arteriolar
responses to pressure were observed by a stepwise increase in
renal arterial pressure. After the reduction of renal arterial
pressure to 80 mm Hg, IAA-94 was added directly to the perfusate
to achieve a concentration of 30 jiM [17]. Subsequently, pressure
challenge was again performed. Following to the restoration of
pressure to 80 mm Hg, Ang 11(0.03 to 0.3 nM) was administered.
Finally, the potassium concentration of media was increased
isoosmotically up to 30 mEq/liter [24] to examine the effects of
IAA-94 on afferent arteriolar response to KCI depolarization.
In the third series of studies, the effects of low chloride media
on Ang Il-induced afferent arteriolar vasoconstriction were exam-
ined (5 kidneys). Ang II (0.1 nM) was added directly to the
perfusate. Subsequently, extracellular chloride concentration was
isoosmotically decreased to 50 mEq/liter by adding the media (pH
7.4) in which sodium chloride was substituted with sodium
isethionate (Kasei-kogyo Co. Ltd., Tokyo, Japan). Isethionate was
selected as the replacement ion for chloride, based on the
previous data that the afferent arteriole exhibited extremely low
permeability to this anion [25]. In order to avoid changes in Ang
II concentration, Ang 11(0.1 nM) had been added to low chloride
media before the administration to the recirculating system.
Finally, IAA-94 was added to achieve a final concentration of 30
In the fourth series of experiments (4 kidneys), after the basal
afferent arteriolar diameter was observed, chloride concentrations
in the perfusate were isoosmotically decreased to 50 mEq/liter,
similarly to the third group. Subsequently, Ang II was adminis-
tered directly to the media to achieve concentrations from 0.03 to
0.3 nM.
In the fifth series of experiments, the influence of low chloride
media on myogenic responsiveness was assessed in five kidneys.
After the basal afferent arteriolar diameter was observed, the
renal arterial pressure was increased from 80 to 120 and then 160
mm Hg. At 160 mm Hg, low chloride media was administered to
decrease chloride concentration to 50 mEq/liter. Subsequently,
renal arterial pressure was decreased initially to 120 and then to
80 mm Hg.
In the sixth series of studies, the effects of low chloride media
on norepinephrine (NE)-induced afferent arteriolar vasoconstric-
tion were examined. Kidneys (N = 5) were initially treated with
propranolol (3 jiM) to prevent f3-adrenergic stimulation by NE
[26]. Then, NE (0.1 jiM) was administered directly to the perfus-
ate. Subsequently, chloride concentrations were reduced to 50
mEq/liter by adding low chloride media containing both 0.1 jiM of
NE and 3 jiM of propranolol. Finally, IAA-94 (30 jiM) was added.
In the seventh series of studies (6 kidneys), the effects of
diltiazem on afferent arteriolar constriction by pressure and
norepinephrine were assessed. Initially, renal arterial pressure
was increased from 80 to 120 and then 160 mm Hg. After the
perfusion pressure returned to 80 mm Hg, diltiazem (10 jiM) was
added. Then, the pressure challenge was again performed. Fol-
lowing the pressure restoration to 80 mm Hg, propranolol (3 jiM)
was added. Finally, NE (0.1 jiM) was administered.
Ang II, NE, propranolol and diltiazem were obtained from
Sigma. IAA-94 was obtained from Research Biochemical Incor-
porated (Natick, MA, USA). Stock solutions of Ang II and
diltiazem were prepared in water and kept frozen until usage.
Solutions of NE and IAA-94 were freshly prepared on the day of
the experiment in water and alcohol, respectively. Propranolol
was dissolved in water.
Statistics
Data are expressed as means SE. Statistical significance was
determined by Student's t-tests, and analysis of variance
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Fig. 1. The effects of diltiazem on afferent arteriolar (AA) responses to
angiotensin II (Ang II) and pressure. Increasing doses of Ang II induced
progressive AA constriction. At 0.3 n, Ang II decreased AA diameter by
33 3%. Subsequent addition of diltiazem reversed Ang 11-induced AA
constriction in a dose-dependent manner. At 10 jiM, diltiazem restored the
decrements in AA diameter. In the presence of diltiazem (10 jiM), the
variations in renal arterial pressure (RAP) failed to alter afferent arterio-
lar diameter. *Significant difference from the basal value.
(ANOVA) followed by Newmann-Keuls test. P values less than
0.05 were considered to he statistically significant.
Results
Figure 1 summarized the effects of diltiazem, a calcium channel
blocker, on afferent arteriolar constriction by Ang II and pressure.
Addition of Ang II elicited dose-dependent afferent arteriolar
constriction. Significant decrease in afferent arteriolar diameter
was obtained by the addition of 0.1 nM of Ang II (from 19.0 0.6
to 16.3 0.6 jim, N = 5, P < 0.01). At 0.3 nM of Ang II, the
afferent arteriole exhibited further decrease in diameter by 33
3% (to 12.9 0.2 j.rm,P < 0.01 vs. basal). Subsequent addition of
diltiazem reversed Ang 11-induced afferent arteriolar constriction
in a concentration-dependent manner. At 1 jiM, diltiazem re-
versed Ang IT-induced afferent arteriolar constriction (to 14.8
0.5 jim,P < 0.05 vs. Ang II 0.3 nM). Complete recovery in afferent
arteriolar diameter was observed at 10 jiM of diltiazem (to 18.9
0.6 jim, MS vs. basal). In the presence of 10 jiM of diltiazem, the
pressure stimuli failed to alter afferent arteriolar diameter (to
19.0 0.5 and 19.0 0.6 jim, at 120 and 160 mm Hg,
respectively).
The effects of IAA-94 on afferent arteriolar constriction by Ang
II and pressure are shown in Figure 2. Under control conditions
the myogenic response was well preserved. The elevation of renal
arterial pressure from 80 to 120 mm Hg constricted afferent
arterioles by 12 2% (from 19.3 0.8 to 16.9 0.6 jim, N = 7,
P < 0.01). A further increase in pressure to 160 mm Hg induced
a progressive afferent arteriolar constriction by 20 2% (to
15.4 0.8 jim, P < 0.01). Pressure reduction to 80 mm Hg
restored the decrements in afferent arteriolar diameter to 19.2
0.8 jim (NS vs. basal). The addition of IAA-94 (30 jiM) did not
alter the basal afferent arteriolar diameter (to 19.1 0.8 jim). In
the presence of TAA-94, increasing the pressure from 80 to 160
mm Hg elicited afferent arteriolar constriction by 21 2% (to
15.3 0.7 jim, P < 0.01 vs. basal), indicating that myogenic
responsiveness was preserved during the chloride channel block-
ade. Pressure restoration to 80 mm Hg returned afferent arterio-
lar diameter to 19.1 0.9 jim (NS vs. basal). In contrast to the
pressure response, subsequent administration of Ang II up to 0.3
n failed to constrict the afferent arteriole (18.7 0.8 jim at 0.3
nM of Ang II, NS vs. basal). However, increasing potassium
concentrations in the perfusate (from 4 I to 28 3 mEq/liter,
P < 0.01) constricted the afferent arteriole by 30 3% (to 13.5
0.7 jim, P < 0.01).
To ascertain whether or not the increase in chloride conduc-
tance plays an important role in afl'erent arteriolar response to
Ang II, we performed additional experiments under the condi-
tions in which extracellular chloride concentration was reduced.
Figure 3 illustrates a representative tracing of afferent arteriolar
response to Ang II and low chloride media. Ang 11(0.1 nM)
constricted an afferent arteriole from 20.1 to 17.3 jim. The
subsequent addition of low chloride perfusate induced a further
decrease in afferent arteriolar diameter to 14.5 jim. Finally, the
administration of IAA-94 (30 jiM) restored the decrements in Ang
Il-induced afferent arteriolar diameter to 19.3 jim. The mean data
obtained from this series of experiments are summarized in
Figure 4. The addition of Ang 11(0.1 nM) elicited an afferent
arteriolar constriction by 13 2% (from 20.5 0.4 to 17.9 0.2
jim, N = 6, P < 0.05). The reduction in extracellular chloride
concentration (from 114 3 to 51 3 mEq/liter, P < 0.01)
potentiated the magnitude of Ang lI-induced afferent arteriolar
constriction by 20 3% (to 16.4 0.4 jim, P < 0.05 vs. Ang II).
The administration of IAA-94 (30 jiM) reversed afferent arteriolar
constriction to 19.6 0.4 jim (P < 0.05 vs. low chloride).
As shown in Figure 5, afferent arteriolar diameter was not
altered (from 20.2 0.7 to 20.0 0.8 jim, N = 5) by decreasing
extracellular chloride concentration (113 3 to 52 2 mEq/Iiter,
P < 0.01) in the absence of vasoconstrictors. These findings are
consistent with the observations that IAA-94 did not alter basal
afferent arteriolar diameter, and suggest that under control
conditions, chloride conductance only plays a small role in
determining the afferent arteriolar tone. In contrast, the subse-
quent addition of Ang 11 resulted in marked afferent arteriolar
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Fig. 2. Effects of L4A-94 on afferent arteriolar
(AA) responses to angiotensin If (Ang II) and
pressure. Increasing renal arterial pressure(RAP) from 80 to 160 mm Hg constricted AAs
by 20 2%. Pressure reduction to 80 mm Hg
restored the decrements in AA diameter. The
addition of IAA-94 (30 jIM) failed to alter both
the basal AA diameter and myogenic
responsiveness. Although the administration of
Ang 11(0.03 to 0.3 nM) did not constrict the
AA in the presence of IAA-94, the increase in
potassium concentration constricted AAs by
30 3%. *Significant difference from the basal
value.
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Fig. 3. A representative tracing illustrating the effects of decreasing extracel-
lular chloride concentration on angiotensin II (Ang 11)-induced afferent
arteriolar (AA) constriction. Ang 11(0.1 nM) considerably constricted AAs.
Decreasing chloride concentrations elicited further decrease in AA diam-
eter. IAA-94 reversed this AA constriction.
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Fig. 4. Line graph showing the effects of low chloride media on afferent
arteriolar (AA) response to angiotensin II (Ang II). The addition of Ang II
(0.1 nM) elicited AA constriction by 13 2%. Decreasing the extracellular
chloride concentration enhanced the magnitude of Ang Il-induced AA
constriction with a resultant 20 3% reduction in diameter. The
administration of IAA-94 (30 ji.M) restored the decrements in AA
diameter by Ang II. , # and + represent P < 0.05 from the basal, Ang II
and low chloride states, respectively.
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constriction. At 0.03 nM, Ang II decreased the afferent arteriolar
diameter to 18.5 0.8 xm (P < 0,05). In low chloride media, the
afferent arteriole was constricted to 15.6 0.8 and 10.0 0.5 .tm
(P < 0.01 for both) at 0.1 and 0.3 nM of Ang II, respectively.
Afferent arteriolar responsiveness to Ang II was compared
between the control conditions and in the presence of IAA-94 or
in low chloride media. Data are expressed as percent changes in
diameter. Although Ang II (0.1 nM) constricted the afferent
arteriole by 13 2% (N = 11) in control conditions, an identical
dose of Ang II failed to alter the afferent arteriolar diameter in
the presence of IAA-94 (2 1%, N = 7, 1' < 0.05 vs. control).
Similarly, at 0.3 nM, Ang II elicited a 33 3% decrease in the
afferent arteriolar diameter in the control conditions (N = 5),
whereas the treatment with IAA-94 markedly attenuated the Ang
11(0.3 nM)-iflduced afferent arteriolar constriction (by 3 2%,
N = 7, P < 0.01 vs. control). Thus, the Ang 11-induced afferent
arteriolar constriction was virtually abolished by the chloride
channel blockade with IAA-94. In contrast, the magnitude of Ang
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Fig. 5. Afferent arteriolar (AA) responses to angiotensin II (Ang II) in a low
chloride condition. Although the addition of low chloride media did not
alter the afferent arteriolar diameter by itself, it enhanced the magnitude
of afferent arteriolar constriction by Ang II. *significance from the basal
value.
Il-induced afferent arteriolar constriction was exaggerated in low
chloride media. At 0.1 nM, Ang II elicited an augmented degree of
afferent arteriolar constriction of 21 2% in the low chloride
condition (N = 11,P < 0.01 vs. control). Low chloride media also
enhanced the Ang 11(0.3 nM)-mduced afferent arteriolar respon-
siveness, resulting in a 50 5% decrease in afferent arteriolar
diameter (N = 5, P < 0.01 vs. control).
Figure 6 shows the results of the experiments performed to
assess whether or not the changes in chloride conductance were
involved in myogenic response, because chloride channels that
were insensitive to IAA-94 might participate in the myogenic
response. Increasing the renal arterial pressure from 80 to 120
mm Hg constricted the afferent arteriole from 20.2 0.8 to 17.2
0.9 sm (N = 6, P < 0.05). A further increase in perfusion pressure
to 160 mm Hg reduced the afferent arteriolar diameter to 16.0
0.8 jim (P < 0.01). In contrast to the Ang II response, the
subsequent addition of low chloride media, which resulted in the
decrease in chloride concentrations from 115 4 to 52 3
mEq/liter (P < 0.01), did not induce further alterations in afferent
arteriolar diameter (to 16.4 0.8 jim). The decrease in pressure
to 120 mm Hg vasodilated afferent arterioles to 17.3 1.0 jim.
The restoration of pressure to 80 mm Hg returned the afferent
arteriolar diameter to 20.3 0.8 jim (NS vs. basal). To facilitate
comparisons, the data were converted to percent changes from
the values obtained at 80 mm Hg. Under control conditions,
increasing the renal arterial pressure from 80 to 120 mm Hg
constricted the afferent arteriole by 15 1%. Further elevation of
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Fig. 6. Effects of low chloride media on myogenic responsiveness. Increasing
the renal arterial pressure (RAP) induced a progressive afferent arteriolar
(AA) constriction. Decreasing chloride failed to alter the AA diameter at
160 mm Hg. At each RAP, myogenic responsiveness was similar between
the two conditions. *significance from the basal value.
pressure to 160 mm Hg reduced the afferent arteriolar diameter
by 21 2%. Under low extracellular chloride conditions, the
decreases in afferent arteriolar diameter were 14 2 and 19 2%
at 120 and 160 mm Hg, respectively. Thus, decreasing the chloride
concentration in the perfusate failed to alter myogenic respon-
siveness.
To examine the potential role of chloride channels in afferent
arteriolar constriction by the other (non-peptide) agonists, the
effects of lowering chloride concentrations on NE-induced affer-
ent arteriolar constriction were assessed. These results are de-
scribed in Figure 7. The treatment with propranolol (3 jiM) failed
to alter the afferent arteriolar diameter (from 21.1 1.0 to 21.0
0.9 jim). The stimulation of a-adrenergic receptors with NE (0.1
jiM) elicited an afferent arteriolar constriction by 14 2% (to
18.4 0.9 jim, N = 6, P < 0.05), suggesting that the afferent
arteriole is more sensitive to Ang II approximately by 1000 times
than NE, because a similar magnitude of afferent arteriolar
constriction was induced by 0.1 nM of Ang 11(13 2%, N = 6).
Subsequent reductions in extracellular chloride concentrations
(from 115 3 to 53 2 mEq/liter, P < 0.01) exaggerated the
magnitude of NE-induced afferent arteriolar constriction to 19
2% (to 17.1 1.0 j.tm, P < 0.05 vs. NE). The subsequent
administration of IAA-94 (30 jiM) substantatively reversed this
afferent arteriolar constriction to 20.3 1.0 jim (NS vs. basal).
Figure 8 summarized the effects of diltiazem on the nlyogenic
response. In control conditions, the increase in renal arterial
pressure from 80 to 120 mm Hg constricted the afferent arteriole
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from 19.1 0.9 to 17.0 0.8 m (N = 6, P < 0.05). At 160 mm
Hg, the afferent arteriole was further constricted (to 15.4 0.7
.Lm, P < 0.01). Pressure restoration to 80 mm Hg returned the
afferent arteriolar diameter to 19.0 0.9 .tm (NS vs. basal).
Although the addition of diltiazem (10 JIM) did not alter the
afferent arteriolar diameter at 80 mm Hg (to 19.2 1.0 ism), it
blocked the pressure-induced afferent arteriolar constriction. In
the presence of diltiazem, the afferent arteriolar diameter was not
altered by variations in pressure, and averaged 19.2 0.9 and
19.0 0.8 m at 120 and 160 mm Hg, respectively.
Subsequently, we examined the effects of diltiazem (10 j.LM) on
NE-induced afferent arteriolar constriction. The kidneys were
treated with propranolol to avoid the /3-adrenergic action of NE,
though it did not induce changes in the afferent arteriolar
diameter (from 19.2 1.0 to 19.2 0.9 JIm). Figure 9 exhibits a
temporal profile of the afferent arteriolar response to cs-adrener-
gic stimulation by NE in the presence of diltiazem. The afferent
arteriolar diameter was transiently decreased from 18.7 to 17.5
jim following the NE administration, but sustained vasoconstric-
tion was not observed in the presence of diltiazem. The mean data
from these experiments are shown in Figure 10. In the presence of
diltiazem, the peak value of transient decrease in afferent arterio-
lar diameter by NE (0.1 jiM) was —1.2 0.3 jim (N = 6, P < 0.05
vs. 0). However, diltiazem prevented a sustained afferent arterio-
lar constriction by NE (—0.1 0.2 jim, NS vs. 0).
Discussion
Signal transduction involved in vasoconstriction has been ex-
tensively investigated, primarily using isolated vascular smooth
muscle from large vessels. Vasoconstrictors such as NE bind to
the specific receptors on vascular smooth muscle cells and induce
phosphatidyl-inositol breakdown [27J. The increase in inositol
trisphosphate or calcium mobilization elicits membrane depolar-
I _____________________________________
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80
Fig. 8. Effects of diltiazem (10 jiM) on pressure-induced afferent arteriolar
(AA) constriction. In control conditions (0), the myogenic response was
well preserved. Increasing the renal arterial pressure (RAP) from 80 to
160 mm Hg decreased afferent arteriolar diameter by 19 2%. Myogenic
response was blocked by diltiazem (0). *significance from the basal value.
ization by opening chloride and/or cation channels [28—30],
thereby inducing the activation of voltage-dependent calcium
channels, the increase in calcium influx and resultant vasocon-
striction [31, 32]. However, the post-receptor mechanisms trig-
gered by constrictor stimuli are not well characterized in the renal
microcirculation and may differ from those of large vessels.
Furthermore, the cellular mechanisms mediating renal microvas-
cular constriction may differ among different vasoconstrictor
stimuli.
Afferent arteriolar constriction by Ang II and pressure appears
to be mediated, at least partly, by a common mechanism. Car-
mines and Navar [11 showed that calcium antagonists blocked Ang
Il-induced afferent arteriolar constriction, suggesting that Ang II
constricts the afferent arteriole by activating voltage-dependent
calcium channels. Similarly, in the present study we demonstrated
that Ang Il-induced afferent arteriolar constriction is reversed by
diltiazem, a calcium antagonist. In addition, Carmines, Inscho and
Gensure [71 revealed that increasing pressure constricts preglo-
merular vessels including the afferent arteriole, mediating renal
autoregulatory responses. In the present study, we have shown
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Fig. 7. Effects of low chloride media on afferent arteriolar (AA) response to
norepinephrine (NE). The addition of NE (0.1 jiM) elicited an AA
constriction by 14 2%. Reducing the extracellular chloride concentra-
tion augmented the magnitude of NE-induced AA constriction to 19
2%. The administration of IAA-94 (30 jiM) restored the decrements in
AA diameter by NE. , # and + represent P < 0.05 from the basal, NE
and low chloride conditions, respectively.
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Fig. 9. A representative tracing illustrating the effects of norepinephrine (NE)
on afferent arteriolar (.44) diameter in the presence of diltiazem. As evident,
NE (0.1 j.M) only transiently constricted AA in the presence of diltiazem
(10 MM).
that pressure-induced afferent arteriolar constriction is abolished
by the calcium antagonist, indicating that the myogenic response
is also mediated by voltage-dependent calcium channels. Thus,
both Ang II and pressure appear to elicit afferent arteriolar
constriction by activating L-type calcium channels.
Recent progress in smooth muscle physiology reveals that
chloride ions play an important role in determining its tone. The
distribution of chloride across cell membrane appears to be varied
among diverse cells, and influenced by the activities of chloride
pumps and/or transporters [331. Ample evidence indicates that in
smooth muscle cells, chloride is accumulated in the cytoplasm at
concentrations significantly exceeding those anticipated by elec-
trochemical equilibrium [34]. Thus, reversal potentials for chlo-
ride in vascular smooth muscle cells have been reported as —30 to
—10 mV [35, 36], substantatively higher potentials than resting
potentials. Hence, the increase in chloride conductance would
depolarize vascular smooth muscle cells. In accordance with these
observations, utilizing arterial vascular smooth muscle Amedee,
Large and Wang [28] showed that the chloride current contrib-
uted to NE-induced membrane depolarization. Furthermore, we
demonstrated that the treatment with IAA-94, a chloride channel
blocker, attenuates endothelin-induced afferent arteriolar con-
striction with preventing membrane depolarization by this peptide
[17]. These findings raise the possibility that the activation of
chloride channels may constitute the ionic basis for membrane
depolarization by various vasoconstrictor stimuli.
Utilizing isolated afferent arterioles, Bührle, Nobiling and
Taugner [12] demonstrated that Ang II depolarizes the afferent
arteriole. Similarly, Kurtz and Penner [13] described that using
juxtaglomerular cells, Ang II induced substantial membrane de-
polarization, which was mediated, at least in part, by the increase
in chloride conductance. We extended these investigations on the
roles of chloride channels in Ang II and the effects of its
constrictor responses in intact renal microvasculature, Our
present results are consistent with the findings cited above [12,
13], and further indicate that the chloride channel blockade with
IAA-94 prevents and reverses Ang Il-induced afferent arteriolar
constriction. In addition, the present observations exhibit that
high potassium media, which exclusively activate voltage-depen-
dent calcium channels [24], are able to constrict afferent arterioles
in the presence of IAA-94. These results indicate that IAA-94
does not interact nonspecifically with potassium or calcium chan-
nels, supporting the specificity of this blocker to chloride channels.
As shown above, we have demonstrated that diltiazem restored
Ang Il-induced decrements in afferent arteriolar diameter. We
also previously demonstrated that Ang TI-induced afferent arte-
riolar constriction is completely reversed by losarten [37]. Thus,
our data suggest that Ang II receptor (AT1) stimulation opens
chloride channels on the afferent arteriole, thereby eliciting
membrane depolarization that activates voltage-dependent cal-
cium channels with resultant constriction.
Our observations that in the presence of IAA-94, the addition
of Ang II elicited neither transient nor sustained afferent arterio-
lar constriction may reflect the possible action of IAA-94 to
deplete intracellular calcium. However, our previous studies
render this possibility unlikely. We demonstrated that IAA-94 did
not modify transient elevation of cytosolic calcium in response to
endothelin, but curtailed the sustained increase in calcium [17],
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Fig. 10. Effects of norepinephrine (NE) on the afferent arteriolar (AA)
diameter when the kidneys were pretreated with diltiazem. NE (0.1 jzM)
induced a modest and transient AA constriction, but sustained AA
constriction was prevented by diltiazem (10 jLM). *p < 0.05 from zero.
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suggesting that the calcium store was intact. Alternatively, the
reasons for the lack of transient afferent arteriolar constriction by
Ang IT in the presence of IAA-94 may relate to the manner in
which Ang II was administered. Continued exposure to subcon-
strictor dose of Ang II might have reduced the calcium store,
thereby attenuating transient vasoconstriction.
In complementary experiments, we have observed the effects of
low chloride perfusate on Ang TI-induced afferent arteriolar
constriction. We performed these series of experiments to assess
whether or not the alterations in extracellular chloride concentra-
tions, which would modify chloride equilibrium potential, influ-
ence the magnitude of Ang TI-induced afferent arteriolar constric-
tion. Our data indicate that decreasing the extracellular chloride
concentration induces a greater magnitude of afferent arteriolar
constriction by Ang TI. These results are compatible with those
from the studies using IAA-94, and suggest that the increase in
chloride conductance plays an important role in mediating affer-
ent arteriolar constriction by Ang TI. Our present findings appear
to be consistent with those of Navar et al [381, who demonstrated
that administration of low NaCI superfusate to interstitial tissue
induces afferent arteriolar constriction in blood-perfused jux-
tamedullary nephrons, in which the afferent arteriole would be
exposed to endogenous Ang II. Taken together, these data
suggest that chloride gradient plays a crucial role in determining
afferent arteriolar responsiveness to Ang II.
Previous studies showed that NE opened chloride channels and
depolarized vascular smooth muscle [28, 36]. In the present study,
we have demonstrated that NE-induced sustained afferent arte-
riolar constriction is blocked by diltiazem, a calcium antagonist.
Our recent results indicated that NE-induced afferent arteriolar
constriction was reversed by calcium antagonists [39]. Further-
more, our present data indicate that afferent arteriolar constric-
tion induced by a-adrenergic stimulation is potentiated in low
chloride media and is reversed by IAA-94. Taken together, these
results suggest that, similarly to Ang II, chloride channels play an
important role in activating voltage-dependent calcium channels
that mediate afferent arteriolar constriction by NE. In addition,
we have recently provided evidence that endothelin constricts the
afferent arteriole by gating chloride channels [17]. The stimula-
tions of a-adrenergic, Ang II (AT1) and endothelin receptors are
coupled with phosphatidyl-inositol breakdown, thereby increasing
inositol trisphosphate that induces a calcium release from endo-
plasmic reticulum [27, 29, 40, 411. Thus, the chloride channels
responsible for agonist-induced afferent arteriolar constriction
seem to be activated by the increase in cytosolic calcium. Collec-
tively, our data are consistent with the proposal that the mecha-
nisms mediating afferent arteriolar constriction induced by the
agonists, which elicit initial calcium mobilization, involve calcium-
activated chloride channels. Indeed, our observations that NE
elicited transient afferent arteriolar constriction in the presence of
diltiazem are consistent with the notion mentioned above, and
support the specificity of diltiazem to voltage-dependent calcium
channels at concentrations used in this study.
In contrast to the responses to Ang IT and NE, the cellular
mechanisms mediating pressure-induced afferent arteriolar con-
striction seem to be independent of chloride channels. Although
several investigators reported the participation of various types of
ionic channels in myogenic response, their results do not provide
a consistent pattern. On the one hand, Davis, Donovitz and Hood
[421 demonstrated that stretched vascular smooth muscle cells of
coronary arteries manifests the opening of nonselective cation
channels. On the other hand, Roman and Harder [14] describe
that the inhibition of calcium-activated potassium channels might
be involved in myogenic response of renal arcuate artery. How-
ever, Loutzenhiser and Parker [16] have shown that afferent
arteriolar myogenic constriction is preserved in the presence of
tetraethylammonium. In the present study, pressure-induced af-
ferent arteriolar constriction was blocked by diltiazen, but was not
altered by either IAA-94 or low chloride media. Our data suggest
that the mechanisms underlying myogenic response involve the
activation of voltage-dependent calcium channels, but not chlo-
ride channels on the afferent arteriole. Since the afferent arteriole
plays the most important role in resistance adjustments in re-
sponse to variations in pressure [7], the precise mechanisms
mediating myogenic response, which substantially contribute to
renal autoregulation, remain to be determined.
Finally, a caveat is in order. Tubuloglomerular feedback (TGF)
participates in renal autoregulation [381. Furthermore, chloride
plays an important role in TGF as a tubular signal [43]. The usage
of low chloride perfusate might mislead the role of chloride
channels in myogenic response, because decreasing chloride in
ultrafiltrate may reduce the afferent arteriolar tone by removing
the constrictor signals from TGF. However, hydronephrosis is
characterized by tubular atrophy [191, which would attenuate
TGF. In addition, we showed that under our experimental condi-
tions, the magnitude of pressure-induced constriction is decreased
at afferent arteriolar segments close to glomerulus [9], the effector
site of TGF [8], indicating that TGF is not operating efficiently in
our model. Thus, it is unlikely that the actions of TGF confound
the interpretation of the present results. Collectively, these find-
ings suggest that pressure-induced afferent arteriolar constriction
in this model represents TGF-independent myogenic constriction.
In summary, the present data using isolated perfused hydrone-
phrotic kidneys indicate that Ang II, NE and increasing pressure
substantatively constrict the afferent arteriole. Furthermore, our
results provide evidence that both Ang II and NE constrict the
afferent arteriole by opening chloride channels and consequently
activate voltage-dependent calcium channels. Finally, the present
findings suggest that the afferent arteriolar myogenic response is
mediated by activating voltage-dependent calcium channels inde-
pendently of chloride channels.
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